IH vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

IH

48.6
AI Score
VS
UTI Wins

UTI

49.6
AI Score

Investment Advisor Scores

IH

49score
Recommendation
HOLD

UTI

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IH UTI Winner
Revenue 115.40M 835.62M UTI
Net Income 13.64M 63.02M UTI
Net Margin 11.8% 7.5% IH
Operating Income 9.55M 83.47M UTI
ROE 9.6% 19.2% UTI
ROA 7.0% 7.6% UTI
Total Assets 195.67M 826.14M UTI
Cash 164.61M 127.36M IH
Current Ratio 3.57 1.07 IH

Relative Price Performance (Last 90 Days)

IH 1M: +0.0% · 3M: -17.6% UTI 1M: -38.0% · 3M: -39.4%

Current Technical Phase

IH

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -7.8%) with fading momentum, RSI 49

RSI (14): 48.6 · Price: $1.36

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.8%), weak momentum, RSI 28

RSI (14): 27.6 · Price: $25.15

Fundamentals Snapshot

Metric IH UTI
Market Cap
Forward P/E 58.8 34.2
Trailing P/E 6.6 42.4
Revenue (TTM)
Revenue Growth -0.1% 0.1%
Gross Margin 0.7% 0.6%
Operating Margin -0.1% 0.0%
EPS 0.20 0.61
Dividend Yield 0.04%

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.